107 related articles for article (PubMed ID: 3871235)
21. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
22. [Influence of pulmonary artery perfusion with solution of washed red blood cells on lung injury after cardiopulmonary bypass].
Song Y; Gong XJ; Gu XH; Li R; Zhang G; Zhang XQ
Zhonghua Yi Xue Za Zhi; 2006 May; 86(20):1421-4. PubMed ID: 16796928
[TBL] [Abstract][Full Text] [Related]
23. Beneficial effects of modern perfusion concepts in aortic valve and aortic root surgery.
Kutschka I; Skorpil J; El Essawi A; Hajek T; Harringer W
Perfusion; 2009 Jan; 24(1):37-44. PubMed ID: 19567547
[TBL] [Abstract][Full Text] [Related]
24. Infusion of autologous platelet rich plasma does not reduce blood loss and product use after coronary artery bypass. A prospective, randomized, blinded study.
Tobe CE; Vocelka C; Sepulvada R; Gillis B; Nessly M; Verrier ED; Hofer BO
J Thorac Cardiovasc Surg; 1993 Jun; 105(6):1007-13; discussion 1013-4. PubMed ID: 8501929
[TBL] [Abstract][Full Text] [Related]
25. Minimal extracorporeal circulation and off-pump compared to conventional cardiopulmonary bypass in coronary surgery.
Panday GF; Fischer S; Bauer A; Metz D; Schubel J; El Shouki N; Eberle T; Hausmann H
Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):832-6. PubMed ID: 19671581
[TBL] [Abstract][Full Text] [Related]
26. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
El-Hamamsy I; Stevens LM; Carrier M; Pellerin M; Bouchard D; Demers P; Cartier R; Page P; Perrault LP
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):7-12. PubMed ID: 17198774
[TBL] [Abstract][Full Text] [Related]
27. Prospective randomized study comparing coronary artery bypass grafting with the new mini-extracorporeal circulation Jostra System or with a standard cardiopulmonary bypass.
Remadi JP; Rakotoarivelo Z; Marticho P; Benamar A
Am Heart J; 2006 Jan; 151(1):198. PubMed ID: 16368318
[TBL] [Abstract][Full Text] [Related]
28. Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations.
Ovrum E; Am Holen E; Abdelnoor M; Oystese R; Ringdal ML
J Thorac Cardiovasc Surg; 1993 Jan; 105(1):78-83. PubMed ID: 8419712
[TBL] [Abstract][Full Text] [Related]
29. Effects of shed mediastinal blood on cardiovascular and pulmonary function: a randomized, double-blind study.
Boodhwani M; Nathan HJ; Mesana TG; Rubens FD;
Ann Thorac Surg; 2008 Oct; 86(4):1167-73. PubMed ID: 18805154
[TBL] [Abstract][Full Text] [Related]
30. Safety and preliminary efficacy of hemoglobin raffimer for patients undergoing coronary artery bypass surgery.
Hill SE; Gottschalk LI; Grichnik K
J Cardiothorac Vasc Anesth; 2002 Dec; 16(6):695-702. PubMed ID: 12486649
[TBL] [Abstract][Full Text] [Related]
31. Beating heart revascularization with or without cardiopulmonary bypass: evaluation of inflammatory response in a prospective randomized study.
Wan IY; Arifi AA; Wan S; Yip JH; Sihoe AD; Thung KH; Wong EM; Yim AP
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1624-31. PubMed ID: 15173716
[TBL] [Abstract][Full Text] [Related]
32. Comparison of coronary bypass surgery with and without cardiopulmonary bypass in patients with multivessel disease.
Mack MJ; Pfister A; Bachand D; Emery R; Magee MJ; Connolly M; Subramanian V
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):167-73. PubMed ID: 14752427
[TBL] [Abstract][Full Text] [Related]
33. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
[TBL] [Abstract][Full Text] [Related]
34. Use of an oxygen therapeutic as an adjunct to intraoperative autologous donation to reduce transfusion requirements in patients undergoing coronary artery bypass graft surgery.
Greenburg AG; Kim HW;
J Am Coll Surg; 2004 Mar; 198(3):373-83; discussion 384-5. PubMed ID: 14992738
[TBL] [Abstract][Full Text] [Related]
35. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol.
Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK
Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069
[TBL] [Abstract][Full Text] [Related]
36. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
[TBL] [Abstract][Full Text] [Related]
37. Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting.
Bizzarri F; Scolletta S; Tucci E; Lucidi M; Davoli G; Toscano T; Neri E; Muzzi L; Frati G
J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1181-5. PubMed ID: 11726894
[TBL] [Abstract][Full Text] [Related]
38. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
Ovrum E; Am Holen E; Tangen G; Ringdal MA
Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
[TBL] [Abstract][Full Text] [Related]
39. The effect of preoperative clopidogrel on bleeding after coronary artery bypass surgery.
Kang W; Theman TE; Reed JF; Stoltzfus J; Weger N
J Surg Educ; 2007; 64(2):88-92. PubMed ID: 17462208
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of plasma catecholamine increases during coronary artery bypass and valve procedures.
Engelman RM; Haag B; Lemeshow S; Angelo A; Rousou JH
J Thorac Cardiovasc Surg; 1983 Oct; 86(4):608-15. PubMed ID: 6604846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
